Literature DB >> 32309418

CD44 expression in stem cells and niche microglia/macrophages following ischemic stroke.

Rikako Sawada1,2, Akiko Nakano-Doi1,3, Tomohiro Matsuyama3, Nami Nakagomi4, Takayuki Nakagomi1,3.   

Abstract

BACKGROUND: CD44, an adhesion molecule in the hyaluronate receptor family, plays diverse and important roles in multiple cell types and organs. Increasing evidence is mounting for CD44 expression in various types of stem cells and niche cells surrounding stem cells. However, the precise phenotypes of CD44+ cells in the brain under pathologic conditions, such as after ischemic stroke, remain unclear.
METHODS: In the present study, using a mouse model for cerebral infarction by middle cerebral artery (MCA) occlusion, we examined the localization and traits of CD44+ cells.
RESULTS: In sham-mice operations, CD44 was rarely observed in the cortex of MCA regions. Following ischemic stroke, CD44+ cells emerged in ischemic areas of the MCA cortex during the acute phase. Although CD44 at ischemic areas was, in part, expressed in stem cells, it was also expressed in hematopoietic lineages, including activated microglia/macrophages, surrounding the stem cells. CD44 expression in microglia/macrophages persisted through the chronic phase following ischemic stroke.
CONCLUSIONS: These data demonstrate that CD44 is expressed in stem cells and cells in the niches surrounding them, including inflammatory cells, suggesting that CD44 may play an important role in reparative processes within ischemic areas under neuroinflammatory conditions; in particular, strokes. 2020 Stem Cell Investigation. All rights reserved.

Entities:  

Keywords:  CD44; ischemic stroke; microglia; neuroinflammation; stem cell niche

Year:  2020        PMID: 32309418      PMCID: PMC7154319          DOI: 10.21037/sci.2020.02.02

Source DB:  PubMed          Journal:  Stem Cell Investig        ISSN: 2306-9759


  73 in total

1.  Chondrogenic and adipogenic potential of microvascular pericytes.

Authors:  C Farrington-Rock; N J Crofts; M J Doherty; B A Ashton; C Griffin-Jones; A E Canfield
Journal:  Circulation       Date:  2004-10-04       Impact factor: 29.690

2.  Comparative Characterization of Ischemia-Induced Brain Multipotent Stem Cells with Mesenchymal Stem Cells: Similarities and Differences.

Authors:  Rika Sakuma; Ai Takahashi; Akiko Nakano-Doi; Rikako Sawada; Saeko Kamachi; Mikiya Beppu; Toshinori Takagi; Shinichi Yoshimura; Tomohiro Matsuyama; Takayuki Nakagomi
Journal:  Stem Cells Dev       Date:  2018-08-21       Impact factor: 3.272

3.  Skeletal muscle neural progenitor cells exhibit properties of NG2-glia.

Authors:  Alexander Birbrair; Tan Zhang; Zhong-Min Wang; María Laura Messi; Grigori N Enikolopov; Akiva Mintz; Osvaldo Delbono
Journal:  Exp Cell Res       Date:  2012-09-20       Impact factor: 3.905

4.  Microglia support neural stem cell maintenance and growth.

Authors:  Takeshi K Matsui; Eiichiro Mori
Journal:  Biochem Biophys Res Commun       Date:  2018-08-08       Impact factor: 3.575

5.  Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth.

Authors:  Alexander Pietras; Amanda M Katz; Elin J Ekström; Boyoung Wee; John J Halliday; Kenneth L Pitter; Jillian L Werbeck; Nduka M Amankulor; Jason T Huse; Eric C Holland
Journal:  Cell Stem Cell       Date:  2014-03-06       Impact factor: 24.633

6.  Osteopontin, a macrophage-derived matricellular glycoprotein, inhibits axon outgrowth.

Authors:  Patrick Küry; Philipp Zickler; Guido Stoll; Hans-Peter Hartung; Sebastian Jander
Journal:  FASEB J       Date:  2004-12-29       Impact factor: 5.191

7.  Use of suppression subtractive hybridization for differential gene expression in stroke: discovery of CD44 gene expression and localization in permanent focal stroke in rats.

Authors:  H Wang; Y Zhan; L Xu; G Z Feuerstein; X Wang
Journal:  Stroke       Date:  2001-04       Impact factor: 7.914

8.  Osteopontin mediates survival, proliferation and migration of neural stem cells through the chemokine receptor CXCR4.

Authors:  Monika Rabenstein; Joerg Hucklenbroich; Antje Willuweit; Anne Ladwig; Gereon Rudolf Fink; Michael Schroeter; Karl-Josef Langen; Maria Adele Rueger
Journal:  Stem Cell Res Ther       Date:  2015-05-22       Impact factor: 6.832

9.  A subset of cerebrovascular pericytes originates from mature macrophages in the very early phase of vascular development in CNS.

Authors:  Seiji Yamamoto; Masashi Muramatsu; Erika Azuma; Masashi Ikutani; Yoshinori Nagai; Hiroshi Sagara; Bon-Nyeo Koo; Satomi Kita; Erin O'Donnell; Tsuyoshi Osawa; Hiroyuki Takahashi; Ken-Ichi Takano; Mitsuko Dohmoto; Michiya Sugimori; Isao Usui; Yasuhide Watanabe; Noboru Hatakeyama; Takahiro Iwamoto; Issei Komuro; Kiyoshi Takatsu; Kazuyuki Tobe; Shumpei Niida; Naoyuki Matsuda; Masabumi Shibuya; Masakiyo Sasahara
Journal:  Sci Rep       Date:  2017-06-20       Impact factor: 4.379

10.  Dynamic changes of CD44 expression from progenitors to subpopulations of astrocytes and neurons in developing cerebellum.

Authors:  Masae Naruse; Koji Shibasaki; Shuichi Yokoyama; Masashi Kurachi; Yasuki Ishizaki
Journal:  PLoS One       Date:  2013-01-04       Impact factor: 3.240

View more
  3 in total

1.  Multiplexed mRNA analysis of brain-derived extracellular vesicles upon experimental stroke in mice reveals increased mRNA content with potential relevance to inflammation and recovery processes.

Authors:  Annika Bub; Santra Brenna; Malik Alawi; Paul Kügler; Yuqi Gui; Oliver Kretz; Hermann Altmeppen; Tim Magnus; Berta Puig
Journal:  Cell Mol Life Sci       Date:  2022-05-31       Impact factor: 9.207

2.  Immunohistochemical Detection of Neural Stem Cells and Glioblastoma Stem Cells in the Subventricular Zone of Glioblastoma Patients.

Authors:  Vashendriya V V Hira; Remco J Molenaar; Barbara Breznik; Tamara Lah; Eleonora Aronica; Cornelis J F Van Noorden
Journal:  J Histochem Cytochem       Date:  2021-02-17       Impact factor: 2.479

Review 3.  New Strategies for Stroke Therapy: Nanoencapsulated Neuroglobin.

Authors:  Santos Blanco; Esther Martínez-Lara; Eva Siles; María Ángeles Peinado
Journal:  Pharmaceutics       Date:  2022-08-19       Impact factor: 6.525

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.